2013 | 2 | 240-241
Article title

Strategia leczenia farmakologicznego w stabilnym okresie przewlekłej obturacyjnej choroby płuc

Title variants
Languages of publication
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic pulmonary disease, 2001.
  • Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54(7): 581–586.
  • Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34(3):648–654.
  • In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone.An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group. Chest 1994; 105(5): 1411–1419.
  • Appleton S, Poole P, Smith B, et al. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.Cochrane Database Syst Rev 2006; (3): CD001104.
  • Tashkin DP, Pearle J, Iezzoni D, et al. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.COPD 2009; 96(1): 17–25. doi: 10.1080/15412550902724073.
  • Calverley P, Pauwels R, Vestbo J, et al. TRial of Inhaled STeroids ANd long-acting beta2 agonists study group. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361(9356): 449–456.
  • Barr RG, Bourbeau J, Camargo CA, et al. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; (2): CD002876.
  • Calverley PM, Rabe KF, Goehring UM, et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009; 374(9691): 685–694.
  • Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(8): 741–750. doi: 10.1164/rccm.200904-0492OC. Epub 2009 Jul 30.
  • Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 2008; 371(9629): 2013–2018. doi: 10.1016/S0140-6736(08)60869-7.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.